Related references
Note: Only part of the references are listed.American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly-2011 Update
Laurence Katznelson et al.
Endocrine Practice (2013)
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
Harvinder S. Chahal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
Andrea Giustina et al.
PLOS ONE (2012)
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure
Sven M. Carlsen et al.
CLINICAL ENDOCRINOLOGY (2011)
Resistance to Somatostatin Analogs in Acromegaly
Annamaria Colao et al.
ENDOCRINE REVIEWS (2011)
Growth Hormone, Ghrelin and Peptide YY Secretion after Oral Glucose Administration in Healthy and Obese Women
E. Outeirino-Blanco et al.
HORMONE AND METABOLIC RESEARCH (2011)
Place of Cabergoline in Acromegaly: A Meta-Analysis
Laure Sandret et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
John A. Jane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Ghrelin neutralization during fasting-refeeding cycle impairs the recuperation of body weight and alters hepatic energy metabolism
Susana Sangiao-Alvarellos et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study
Ming Shen et al.
ENDOCRINE JOURNAL (2010)
Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial
Zhi-gang Mao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Altered fasting and postprandial plasma ghrelin levels in patients with liver failure are normalized after liver transplantation
Maria Teresa Diz-Lois et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
Laurence Katznelson
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Pathogenesis of Pituitary Tumors
Sylvia L. Asa et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Guidelines for Acromegaly Management: An Update
S. Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Acromegaly pathogenesis and treatment
Shlomo Melmed
JOURNAL OF CLINICAL INVESTIGATION (2009)
Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
N. Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2008)
Does Preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question
Albert Beckers
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: A prospective, randomized trial
Sven M. Carlsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
AcroBel - the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects
Marie Bex et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Presurgical treatment with somatostatin analogs in patients with acromegaly:: effects on the remission and complication rates
M Losa et al.
JOURNAL OF NEUROSURGERY (2006)
Short-term preoperative octreotide treatment of GH-secreting pituitary adenoma: Predictors of tumor shrinkage
S Oshino et al.
ENDOCRINE JOURNAL (2006)
Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly
A Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Consensus statement: medical management of acromegaly
S Melmed et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
CLINICAL REVIEW: A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly
S Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Presurgical octreotide treatment in acromegaly:: no improvement of final growth hormone (GH) concentration and pituitary function.: A long-term case-control study
U Plöckinger et al.
ACTA NEUROCHIRURGICA (2005)
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'
P Nomikos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Primary medical therapy for acromegaly
MC Sheppard
CLINICAL ENDOCRINOLOGY (2003)
Preoperative lanreotide treatment for GH-secreting pituitary adenomas:: effect on tumour volume and predictive factors of significant tumour shrinkage
T Lucas et al.
CLINICAL ENDOCRINOLOGY (2003)
The pathophysiological consequences of somatostatin receptor internalization and resistance
LJ Hofland et al.
ENDOCRINE REVIEWS (2003)
Pathology of pituitary tumors
N Sanno et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2003)
Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre
T Abe et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)
Share Paper
